Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 20.57 Billion |
| USD 43.46 Billion | |
| % | |
|
Australia Endotoxin Testing Market, By Product Type (Endotoxin Detection Kits & Reagents, Instruments, Systems, and Software, Endotoxin Testing Services and Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test and Recombinant C (RFC) Assay), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production and Packaging Manufacture), Method (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, and Turbidimetric Endotoxin Test), Mode of Purchase (Large Group, Mid and Small Group and Individual), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Academic Research Institute and Others) – Industry Trends and Forecast to 2030.
The rapidly increasing pharmaceutical and medical device industries are a major driver for the market's growth. The rising inclination towards outsourcing to contract manufacturing organizations for endotoxin testing and other contamination testing purposes has increased considerably in recent years. Public and regulatory concerns about product safety would also increase more use of endotoxin testing. High demand for R&D investments in the life sciences industry would also boost the market.
Data Bridge Market Research analyses a growth rate in the Australia endotoxin testing market in the forecast period 2023-2030. The expected CAGR of the endotoxin testing market tends to be around 9.8% in the mentioned forecast period. The market was valued at USD 20.57 million in 2022 and would grow to USD 43.46 million by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2030
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Endotoxin Detection Kits & Reagents, Instruments, Systems, and Software, Endotoxin Testing Services and Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test and Recombinant C (RFC) Assay), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production and Packaging Manufacture), Method (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, and Turbidimetric Endotoxin Test), Mode of Purchase (Large Group, Mid and Small Group and Individual), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Academic Research Institute and Others)
|
|
Market Players Covered
|
Eurofins Scientific (France), Thermo Fisher Scientific (U.S.), Pall Corporation. (U.S.), Lonza (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany), STERIS (U.K.), Société Générale de Surveillance SA (France), Sartorius AG (Germany), and GenScript (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Bacterial endotoxin testing (BET) is a crucial safety condition in the biomedical and pharmaceutical industries. Endotoxins can cause symptoms of septic shock, fever, and pyrogenic reaction if enough of them reach the patient's bloodstream. Identifying bacterial endotoxins is a major safety requirement in the biomedical and pharmaceutical industries. Endotoxin quality-control tests must obey the regulatory criteria laid down by the European and the U.S. Pharmacopeia and the U.S. FDA.
Drivers
The increasing investments in research and development in the pharmaceutical and biotechnology industries lead to market growth. Pharmaceutical, biotech, and numerous drug manufacturing companies use tests such as pyrogen testing for the safe manufacturing and introduction of infection-free products into the market. For instance, major market players in the pharmaceuticals market named, AstraZeneca, Roche, and Merck have invested heavily in R&D activities in 2021. Roche invested about $13.5 billion, up by 14.3% from 2020. Thus, high investments in R&D by pharmaceutical companies boost market growth.
Opportunities
Several new endotoxin testing techniques, such as recombinant factor C assay and monocyte activation test, have been developed and commercially distributed on a large scale due to high technological development. The turbidimetric endotoxin test, also known as the kinetic chromogenic Limulus amebocyte lysate (LAL) assay, is widely used to quantitatively determine bacterial endotoxins in pharmaceutical products and medical devices. The Limulus amebocyte lysate (LAL) test is widely used for drugs and devices in the pharmaceutical and biotechnology industries. Thus, this boosts market growth.
Numerous product launches and agreements are initiated by the companies, accelerating market growth. For instance, Charles River Laboratories launched new solutions named EndoScan-V software platform and Celsis automated detection platform for the sterility to meet pharmaceuticals needs. This new product launched by the company has boosted the company's microbial solutions portfolio, which will increase sales and revenue in the future. Also, WuXi AppTec launched its new medical device laboratory testing center in Suzhou, China, to form a globally integrated medical device testing platform to serve medical device customers and offer endotoxin testing services in 2020. This creates more opportunities in the market.
Restraints/Challenges
There are many regulations associated with endotoxin testing methods that are stringent. These quality control tests are necessary to comply with certain regulations. For instance, ACell Inc., a Maryland-based medical device manufacturer, was found guilty on the charges related to MicroMatrix powder wound dressing product by the Department of Justice in 2019.
This endotoxin testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endotoxin testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The endotoxin testing market is segmented based on product type, test type, application, method, mode of purchase, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
Test Type
Application
Method
Mode of Purchase
End-Users
The endotoxin testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Australia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endotoxin testing market.
Key players operating in the endotoxin testing market include:
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF AUSTRALIA ENDOTOXIN TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL XX SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 AUSTRALIA ENDOTOXIN TESTING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 COST ANALYSIS BREAKDOWN
8 TECHNONLOGY ROADMAP
9 INNOVATION TRACKER AND STRATEGIC ANALYSIS
9.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
9.1.1 JOINT VENTURES
9.1.2 MERGERS AND ACQUISITIONS
9.1.3 LICENSING AND PARTNERSHIP
9.1.4 TECHNOLOGY COLLABORATIONS
9.1.5 STRATEGIC DIVESTMENTS
9.2 NUMBER OF PRODUCTS IN DEVELOPMENT
9.3 STAGE OF DEVELOPMENT
9.4 TIMELINES AND MILESTONES
9.5 INNOVATION STRATEGIES AND METHODOLOGIES
9.6 RISK ASSESSMENT AND MITIGATION
9.7 FUTURE OUTLOOK
10 REGULATORY COMPLIANCE
10.1 REGULATORY AUTHORITIES
10.2 REGULATORY CLASSIFICATIONS
10.2.1 CLASS I
10.2.2 CLASS II
10.2.3 CLASS III
10.3 REGULATORY SUBMISSIONS
10.4 INTERNATIONAL HARMONIZATION
10.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
10.6 REGULATORY CHALLENGES AND STRATEGIES
11 REIMBURSEMENT FRAMEWORK
12 VALUE CHAIN ANALYSIS
13 HEALTHCARE ECONOMY
13.1 HEALTHCARE EXPENDITURE
13.2 CAPITAL EXPENDITURE
13.3 CAPEX TRENDS
13.4 CAPEX ALLOCATION
13.5 FUNDING SOURCES
13.6 INDUSTRY BENCHMARKS
13.7 GDP RATION IN OVERALL GDP
13.8 HEALTHCARE SYSTEM STRUCTURE
13.9 GOVERNMENT POLICIES
13.1 ECONOMIC DEVELOPMENT
14 AUSTRALIA ENDOTOXIN TESTING MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
14.2 ENDOTOXIN DETECTION KITS & REAGENTS
14.2.1 LAL TEST REAGENTS
14.2.2 MYCOPLASMA DETECTION & REMOVAL
14.2.3 PCR MYCOPLASMA DETECTION KIT
14.2.4 MYCOPLASMA ELIMINATION COCKTAIL
14.2.5 OTHERS
14.3 INSTRUMENTS & SYSTEMS
14.3.1 SERIES TUBE READER
14.3.2 MICROPLATE READER
14.3.3 LOW ENDOTOXIN RECOVERY (LER)
14.3.4 ENDOTOXIN REMOVAL
14.3.5 LOW ENDOTOXIN RECOVERY (LER)
14.3.6 OTHERS
14.4 CONSUMABLES & ACCESSORIES
14.4.1 PIPETTE TIPS
14.4.2 MULTIWELL PLATES
14.4.3 MICROPLATES
14.4.4 TUBES
14.4.5 CAPS
14.4.6 OTHERS
14.5 ENDOTOXIN TESTING SERVICES
15 AUSTRALIA ENDOTOXIN TESTING MARKET, BY TEST TYPE
15.1 OVERVIEW
15.2 LIMULUS AMOEBOCYTE LYSATE (LAL) TEST
15.3 MONOCYTE ACTIVATION TEST (MAT) TEST
15.4 RABBIT PYROGEN TEST
15.5 RECOMBINANT FACTOR C (RFC) ASSAY
16 AUSTRALIA ENDOTOXIN TESTING MARKET, BY APPLICATION
16.1 OVERVIEW
16.2 PHARMACEUTICAL MANUFACTURING
16.2.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.2.2 INSTRUMENTS & SYSTEMS
16.2.3 CONSUMABLES & ACCESSORIES
16.2.4 ENDOTOXIN TESTING SERVICES
16.3 MEDICAL DEVICE MANUFACTURING
16.3.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.3.2 INSTRUMENTS & SYSTEMS
16.3.3 CONSUMABLES & ACCESSORIES
16.3.4 ENDOTOXIN TESTING SERVICES
16.4 RAW MATERIALS PRODUCTION
16.4.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.4.2 INSTRUMENTS & SYSTEMS
16.4.3 CONSUMABLES & ACCESSORIES
16.4.4 ENDOTOXIN TESTING SERVICES
16.5 PACKAGING MANUFACTURE
16.5.1 ENDOTOXIN DETECTION KITS & REAGENTS
16.5.2 INSTRUMENTS & SYSTEMS
16.5.3 CONSUMABLES & ACCESSORIES
16.5.4 ENDOTOXIN TESTING SERVICES
17 AUSTRALIA ENDOTOXIN TESTING MARKET, BY METHOD
17.1 OVERVIEW
17.2 GEL CLOT ENDOTOXIN TEST
17.3 CHROMOGENIC ENDOTOXIN TEST
17.4 TURBIDIMETRIC ENDOTOXIN TEST
18 AUSTRALIA ENDOTOXIN TESTING MARKET, BY MODE OF PURCHASE
18.1 OVERVIEW
18.2 LARGE GROUP
18.3 MID AND SMALL GROUP
18.4 INDIVIDUAL
19 AUSTRALIA ENDOTOXIN TESTING MARKET, BY END USER
19.1 OVERVIEW
19.2 PHARMACEUTICAL COMPANIES
19.2.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.2.2 INSTRUMENTS & SYSTEMS
19.2.3 CONSUMABLES & ACCESSORIES
19.2.4 ENDOTOXIN TESTING SERVICES
19.3 BIOTECHNOLOGY COMPANIES
19.3.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.3.2 INSTRUMENTS & SYSTEMS
19.3.3 CONSUMABLES & ACCESSORIES
19.3.4 ENDOTOXIN TESTING SERVICES
19.4 MEDICAL DEVICE COMPANIES
19.4.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.4.2 INSTRUMENTS & SYSTEMS
19.4.3 CONSUMABLES & ACCESSORIES
19.4.4 ENDOTOXIN TESTING SERVICES
19.5 CONTRACT RESEARCH ORGANIZATION (CRO)
19.5.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.5.2 INSTRUMENTS & SYSTEMS
19.5.3 CONSUMABLES & ACCESSORIES
19.5.4 ENDOTOXIN TESTING SERVICES
19.6 CONTRACT MANUFACTURING ORGANIZATION (CMO)
19.6.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.6.2 INSTRUMENTS & SYSTEMS
19.6.3 CONSUMABLES & ACCESSORIES
19.6.4 ENDOTOXIN TESTING SERVICES
19.7 ACADEMIC RESEARCH INSTITUTES
19.7.1 ENDOTOXIN DETECTION KITS & REAGENTS
19.7.2 INSTRUMENTS & SYSTEMS
19.7.3 CONSUMABLES & ACCESSORIES
19.7.4 ENDOTOXIN TESTING SERVICES
19.8 OTHERS
20 AUSTRALIA ENDOTOXIN TESTING MARKET, SWOT AND DBMR ANALYSIS
21 AUSTRALIA ENDOTOXIN TESTING MARKET, COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: GLOBAL
21.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
21.3 COMPANY SHARE ANALYSIS: EUROPE
21.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
21.5 MERGERS & ACQUISITIONS
21.6 NEW PRODUCT DEVELOPMENT & APPROVALS
21.7 EXPANSIONS
21.8 REGULATORY CHANGES
21.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
22 AUSTRALIA ENDOTOXIN TESTING MARKET, BY REGION
22.1 AUSTRALIA ENDOTOXIN TESTING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
22.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
23 AUSTRALIA ENDOTOXIN TESTING MARKET, COMPANY PROFILE
23.1 LONZA
23.1.1 COMPANY OVERVIEW
23.1.2 REVENUE ANALYSIS
23.1.3 GEOGRAPHIC PRESENCE
23.1.4 PRODUCT PORTFOLIO
23.1.5 RECENT DEVELOPMENTS
23.2 CHARLES RIVER LABORATORIES
23.2.1 COMPANY OVERVIEW
23.2.2 REVENUE ANALYSIS
23.2.3 GEOGRAPHIC PRESENCE
23.2.4 PRODUCT PORTFOLIO
23.2.5 RECENT DEVELOPMENTS
23.3 EUROFINS SCIENTIFIC
23.3.1 COMPANY OVERVIEW
23.3.2 REVENUE ANALYSIS
23.3.3 GEOGRAPHIC PRESENCE
23.3.4 PRODUCT PORTFOLIO
23.3.5 RECENT DEVELOPMENTS
23.4 DANAHER
23.4.1 COMPANY OVERVIEW
23.4.2 REVENUE ANALYSIS
23.4.3 GEOGRAPHIC PRESENCE
23.4.4 PRODUCT PORTFOLIO
23.4.5 RECENT DEVELOPMENTS
23.5 BIOMÉRIEUX SA
23.5.1 COMPANY OVERVIEW
23.5.2 REVENUE ANALYSIS
23.5.3 GEOGRAPHIC PRESENCE
23.5.4 PRODUCT PORTFOLIO
23.5.5 RECENT DEVELOPMENTS
23.6 SARTORIUS AG
23.6.1 COMPANY OVERVIEW
23.6.2 REVENUE ANALYSIS
23.6.3 GEOGRAPHIC PRESENCE
23.6.4 PRODUCT PORTFOLIO
23.6.5 RECENT DEVELOPMENTS
23.7 GENSCRIPT
23.7.1 REVENUE ANALYSIS
23.7.2 GEOGRAPHIC PRESENCE
23.7.3 PRODUCT PORTFOLIO
23.7.4 RECENT DEVELOPMENTS
23.8 MERCK KGAA
23.8.1 COMPANY OVERVIEW
23.8.2 REVENUE ANALYSIS
23.8.3 GEOGRAPHIC PRESENCE
23.8.4 PRODUCT PORTFOLIO
23.8.5 RECENT DEVELOPMENTS
23.9 STERIS PLC
23.9.1 COMPANY OVERVIEW
23.9.2 REVENUE ANALYSIS
23.9.3 GEOGRAPHIC PRESENCE
23.9.4 PRODUCT PORTFOLIO
23.9.5 RECENT DEVELOPMENTS
23.1 SGS SA
23.10.1 COMPANY OVERVIEW
23.10.2 REVENUE ANALYSIS
23.10.3 GEOGRAPHIC PRESENCE
23.10.4 PRODUCT PORTFOLIO
23.10.5 RECENT DEVELOPMENTS
23.11 THERMOFISHER SCIENTIFIC, INC.
23.11.1 COMPANY OVERVIEW
23.11.2 REVENUE ANALYSIS
23.11.3 GEOGRAPHIC PRESENCE
23.11.4 PRODUCT PORTFOLIO
23.11.5 RECENT DEVELOPMENTS
23.12 ACON LABORATORIES, INC
23.12.1 COMPANY OVERVIEW
23.12.2 REVENUE ANALYSIS
23.12.3 GEOGRAPHIC PRESENCE
23.12.4 PRODUCT PORTFOLIO
23.12.5 RECENT DEVELOPMENTS
23.13 BIOMERIEUX S.A.
23.13.1 COMPANY OVERVIEW
23.13.2 REVENUE ANALYSIS
23.13.3 GEOGRAPHIC PRESENCE
23.13.4 PRODUCT PORTFOLIO
23.13.5 RECENT DEVELOPMENTS
23.14 ACCU REFERENCE MEDICAL LABS
23.14.1 COMPANY OVERVIEW
23.14.2 REVENUE ANALYSIS
23.14.3 GEOGRAPHIC PRESENCE
23.14.4 PRODUCT PORTFOLIO
23.14.5 RECENT DEVELOPMENTS
23.15 MILLENIUM HEALTH
23.15.1 COMPANY OVERVIEW
23.15.2 REVENUE ANALYSIS
23.15.3 GEOGRAPHIC PRESENCE
23.15.4 PRODUCT PORTFOLIO
23.15.5 RECENT DEVELOPMENTS
23.16 AVELLINO LABS
23.16.1 COMPANY OVERVIEW
23.16.2 REVENUE ANALYSIS
23.16.3 GEOGRAPHIC PRESENCE
23.16.4 PRODUCT PORTFOLIO
23.16.5 RECENT DEVELOPMENTS
23.17 XCR DIAGNOSTICS
23.17.1 COMPANY OVERVIEW
23.17.2 REVENUE ANALYSIS
23.17.3 GEOGRAPHIC PRESENCE
23.17.4 PRODUCT PORTFOLIO
23.17.5 RECENT DEVELOPMENTS
23.18 CTK BIOTECH, INC.
23.18.1 COMPANY OVERVIEW
23.18.2 REVENUE ANALYSIS
23.18.3 GEOGRAPHIC PRESENCE
23.18.4 PRODUCT PORTFOLIO
23.18.5 RECENT DEVELOPMENTS
23.19 ANP TECHNOLOGIES, INC.
23.19.1 COMPANY OVERVIEW
23.19.2 REVENUE ANALYSIS
23.19.3 GEOGRAPHIC PRESENCE
23.19.4 PRODUCT PORTFOLIO
23.19.5 RECENT DEVELOPMENTS
24 RELATED REPORTS
25 CONCLUSION
26 QUESTIONNAIRE
27 ABOUT DATA BRIDGE MARKET RESEARC
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.